Atherosclerosis and Technology - Cardiovascular Update

Novel UV?B Phototherapy With a Light?Emitting Diode Device Prevents Atherosclerosis by Augmenting Regulatory T?Cell Responses in Mice

Journal of the American Heart Association

JANUARY 12, 2024

BackgroundUltraviolet B (UV‐B) irradiation is an effective treatment for human cutaneous disorders and was shown to reduce experimental atherosclerosis by attenuating immunoinflammatory responses. Our findings indicate that a novel 282 nm UV‐B phototherapy could be an attractive approach to treat atherosclerosis.

Atherosclerosis

Atherosclerosis Plaque Aortic Technology

Cleerly Receives FDA Breakthrough Device Designation for Heart Disease Risk Staging System

DAIC

MARCH 6, 2024

The CAD Staging System is a noninvasive imaging-based investigational software device that analyzes important and actionable features of coronary atherosclerosis, stenosis and ischemia. Cleerly is committed to accelerating the availability of its technology to healthcare providers and patients alike.

Heart Disease

Heart Disease Heart Attack Heart attacks Technology

HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCT

DAIC

JANUARY 23, 2024

Better reimbursement for hospitals leads to improved accessibility to this technology, which is a win for everyone involved, most notably patients.” HeartFlow remains dedicated to reshaping cardiovascular care and ensuring that hospitals have access to comprehensive, accurate, and efficient solutions in precision coronary care.

Reimbursement

Reimbursement Coronary Artery Disease CMS Technology

HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients

DAIC

MAY 8, 2024

1 Atherosclerosis is a systemic disease that affects multiple vascular regions and is particularly severe in PAD patients, where up to 80 percent suffer from concurrent coronary artery disease (CAD), historically linked with a mortality rate exceeding 50 percent within five years.

Coronary Artery Disease

Coronary Artery Disease Chest Pain Myocardial Infarction Ischemia

Elucid Commences International PRE-VUE CCT Registry Study

DAIC

JULY 18, 2024

Cardiovascular disease is the most common cause of death and disability globally, largely driven by myocardial infarction and ischemic stroke caused by atherosclerosis (plaque build-up in the arteries).

Plaque

Plaque Heart Attack Heart attacks Cardiovascular Disease

Innovative Data Featuring Nanox AI Cardiac Solution Showcased at SCCT 2024

DAIC

JULY 25, 2024

mtaschetta-millane Thu, 07/25/2024 - 08:55 July 25, 2024 — Nanox, an innovative medical imaging technology company, announced that the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox.AI was highlighted in multiple scientific presentations at the 2024 Society of Cardiovascular Computed Tomography (SCCT) Annual Meeting. “We

Innovation

Innovation Coronary Artery Disease Hospital Cardiovascular Disease

Brachiocephalic Artery Access for Transcatheter Aortic Valve Replacement

All About Cardiovascular System and Disorders

MAY 19, 2024

Brachiocephalic artery access without sternotomy for TAVR has been described as a Cutting-Edge Technology in a paper which has been just accepted in the JACC Asia [1]. Contralateral or left atherosclerosis in the carotid artery with significant stenosis or occlusion was a contraindication for this approach.

Aortic valve

Aortic valve Aortic TAVR Open-Heart Surgery

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress

JULY 25, 2024

This year’s renowned open-concept exhibit hall will feature industry-leading companies presenting their innovative products, technologies, and services designed to assist practitioners in delivering the best whole-patient care possible. Michos, MD, MHS, FACC, FAHA, FASE, FASPC ; famed hypertension expert Keith C.

Education

Education Innovation Risk Factors Obesity

The Advantages Of A CT Coronary Angiogram

Dr. Paddy Barrett

AUGUST 1, 2023

Historically, the radiation required to perform CTCA scans was relatively high, but with the advent of newer scanning technologies, that dose has been significantly reduced 1. A CT CAC scan can only identify if there is calcified atherosclerosis, where it is and to what extent. And it matters. They are not fantastic odds, in my view.

Coronary Angiogram

Coronary Angiogram Plaque Coronary Artery Disease Chest Pain

Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

DAIC

JANUARY 19, 2024

milla1cf Fri, 01/19/2024 - 10:55 January 19, 2024 — Orchestra BioMed , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the first patient was randomized in the BACKBEAT pivotal study in late December 2023. billion adults worldwide.

Pacemaker

Pacemaker Hypertension Blood Pressure Kidney Disease

News from EHRA 2024: International Experts Agree on Standards for Catheter Ablation of Atrial Fibrillation

DAIC

APRIL 9, 2024

Technological innovations have made catheter ablation safer and more effective than ever before,” Tzeis, who added, “For example, we now have pulsed field ablation which uses high energy electrical pulses to treat atrial fibrillation without damaging the nerves or oesophagus. The risk of death is extremely low (0.05-0.1%). 2018;11(7):e006350.

Atrial Fibrillation

Atrial Fibrillation Ablation Heart Rhythm Blood Clot

APOE4 & Cardiovascular Risk

Dr. Paddy Barrett

AUGUST 22, 2023

Share For those with defective LDL receptors, as seen in familial hyperlipidemia, APOB particles are not cleared effectively, and concentrations rise, causing atherosclerosis 4. Which increases the risk of atherosclerosis. Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. J Lipid Res.

Cholesterol

Cholesterol Dementia Cardiovascular Disease Coronary Artery Disease

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1)

Cardiometabolic Health Congress

AUGUST 8, 2024

Key contributions: Advanced cardiac imaging (e.g., high-sensitivity troponin, NT-proBNP) in risk stratification Utilization of advanced echocardiographic techniques (e.g.,

Education

Education Kidney Disease Cardiovascular Disease Diabetes

Why is ECG machine use? What diseases can EKG monitor detect?

Wellnest

DECEMBER 21, 2022

Technological advancements have revolutionized the medical industry; now, portable ECG devices are also available. This condition is also called atherosclerosis. Lead wires connect these patches to the ECG machine. The machine prints out a graph containing information about the heart's activity.

Cardiac Arrest

Cardiac Arrest Heart Attack Heart attacks Atrial Fibrillation

Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

DAIC

FEBRUARY 13, 2024

According to the company, Earls is a leader within the field of radiology and specializes in applications of advanced imaging technologies in cardiovascular care. He is the author of over 150 articles, book chapters, abstracts and other publications on advanced imaging technologies. Earls, MD , Chief Medical Officer of Cleerly.

Coronary Artery Disease

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging

Do Statins Cause Dementia?

Dr. Paddy Barrett

SEPTEMBER 19, 2023

Atherosclerosis. 9 Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. Curr Opin Lipidol. 2014 Feb;25(1):40-7. 2021 Aug;331:20-27. 7 HAUSER-RCT Investigators. Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. N Engl J Med. 2020 Oct 1;383(14):1317-1327. J Lipid Res.

Dementia

Dementia Cholesterol Biomarkers Circulation

Robust Diagnostic Accuracy and Prognostic Utility in Analyses from Large Scale Clinical Trials

DAIC

MARCH 28, 2024

The study describes the validation of Cleerly's artificial intelligence-guided quantitative coronary CT angiography (AI-QCT) ISCHEMIA technology for diagnostic accuracy and prognostic risk stratification. Earls, MD , Chief Medical Officer of Cleerly.

Ischemia

Ischemia Atherosclerosis Coronary Artery Disease Chest Pain

Novel UV?B Phototherapy With a Light?Emitting Diode Device Prevents Atherosclerosis by Augmenting Regulatory T?Cell Responses in Mice

Cleerly Receives FDA Breakthrough Device Designation for Heart Disease Risk Staging System

HeartFlow Announces New Reimbursement Code and Increased Payment for FFRCT

HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients

Elucid Commences International PRE-VUE CCT Registry Study

Innovative Data Featuring Nanox AI Cardiac Solution Showcased at SCCT 2024

Brachiocephalic Artery Access for Transcatheter Aortic Valve Replacement

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC)

The Advantages Of A CT Coronary Angiogram

Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

News from EHRA 2024: International Experts Agree on Standards for Catheter Ablation of Atrial Fibrillation

APOE4 & Cardiovascular Risk

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1)

Why is ECG machine use? What diseases can EKG monitor detect?

Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease

Do Statins Cause Dementia?

Robust Diagnostic Accuracy and Prognostic Utility in Analyses from Large Scale Clinical Trials

Stay Connected